Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
Background The non-calcium-based phosphate binder sevelamer hydrochloride was developed to provide chronic kidney disease patients with a polymer capable of managing hyperphosphatemia without an increase in the calcium load. These beneficial effects were postulated as the mechanism of decreased prog...
Saved in:
Main Authors: | Bahaa Eldin Zayed (Author), Hussein El-Fishawy (Author), Amal R Al-Shihaby (Author), Mohamed A Salem (Author), Usama A.A. Sharaf El Din (Author), Mona Mansour (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
by: Vincenzo Savica, et al.
Published: (2008) -
Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
by: Darius L. Mason, et al.
Published: (2022) -
Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
by: Makowka A, et al.
Published: (2021) -
Binding interactions with sevelamer and polystyrene sulfonate in vitro
by: Inge R.F. vanBerlo‐van de Laar, et al.
Published: (2021) -
Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013)